Abstract:<p>Oxidized low-density lipoprotein (ox-LDL)-mediated NLRP3 inflammasome activation is crucial in atherosclerosis (AS) initiation and progression. Aldehyde dehydrogenase 2 (ALDH2) has been reported to display protective effects during AS development; however, the underlying mechanisms are largely unknown. Here we investigate the role of ALDH2 in ox-LDL-induced NLRP3 inflammasome priming and activation. We treated RAW264.7 murine macrophages with ox-LDL with or without ALDH2 activator Alda-1 and measured NLRP3 inflammasome priming and activation, ALDH2 protein expression and enzyme activity, IL-1β release, and DNA damage. It was found that ox-LDL impaired ALDH2 activity and induced NLRP3 inflammasome priming and activation. Alda-1 inhibited both of the priming and activation steps of NLRP3 inflammasome as well as subsequent cell pyroptosis and attenuated ROS and 4-HNE levels in ox-LDL-treated macrophages. Taken together, ALDH2 activation inhibits priming and activation of NLRP3 inflammasome via reducing oxidative stress, which suggests that ALDH2 may be a potential target for anti-inflammatory therapies in AS treatment.</p>

What problem does this paper attempt to address?

The key problem that this paper attempts to solve is to explore the role of aldehyde dehydrogenase 2 (ALDH2) in the priming and activation of NLRP3 inflammasome induced by oxidized low - density lipoprotein (ox - LDL) and its underlying mechanisms. Specifically, the research aims to answer the following questions: 1. **Can ALDH2 inhibit the priming and activation of NLRP3 inflammasome induced by ox - LDL?** - The research experimentally verified whether Alda - 1, an ALDH2 activator, can inhibit the priming and activation of NLRP3 inflammasome induced by ox - LDL. 2. **What are the specific mechanisms of ALDH2 in regulating NLRP3 inflammasome?** - The research explored the mechanism by which ALDH2 inhibits the priming and activation of NLRP3 inflammasome by reducing oxidative stress. 3. **Can ALDH2 alleviate ox - LDL - induced pyroptosis?** - The research found that ALDH2 activation can inhibit ox - LDL - induced caspase - 1 activation and IL - 1β maturation, thereby alleviating pyroptosis. ### Specific problem analysis #### 1. The influence of ALDH2 on NLRP3 inflammasome Researchers found through experiments that after RAW264.7 mouse macrophages were treated with ox - LDL, the mRNA expressions of NLRP3 and IL - 1β increased significantly, and promoted the activation of pro - caspase - 1 and pro - IL - 1β. However, after pretreatment with ALDH2 activator Alda - 1, these effects were significantly inhibited. This indicates that ALDH2 can inhibit the priming and activation of NLRP3 inflammasome induced by ox - LDL. #### 2. The mechanism of action of ALDH2 The research further revealed that ALDH2 exerts its inhibitory effect by reducing oxidative stress. Specifically: - Ox - LDL increased ROS generation in RAW264.7 cells, while Alda - 1 treatment significantly decreased ROS levels. - Ox - LDL increased the expression of 4 - HNE (a lipid peroxidation product), while Alda - 1 treatment restored 4 - HNE levels to near - normal levels. #### 3. Alleviating pyroptosis The research also found that ALDH2 activation significantly inhibited ox - LDL - induced caspase - 1 activation and IL - 1β maturation, thereby alleviating pyroptosis. In addition, Alda - 1 treatment significantly alleviated DNA damage, further confirming the role of ALDH2 in alleviating pyroptosis. ### Summary This research revealed the mechanism by which ALDH2 inhibits the priming and activation of NLRP3 inflammasome induced by ox - LDL by reducing oxidative stress, and then alleviates pyroptosis. This finding provides new targets and ideas for anti - inflammatory treatment of AS (atherosclerosis).

Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stress

Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque.

Characterization of the Molecular Mechanisms Underlying Increased Ischemic Damage in the Aldehyde Dehydrogenase 2 Genetic Polymorphism Using a Human Induced Pluripotent Stem Cell Model System.

Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells

Mitochondrial aldehyde dehydrogenase activity protects against lipopolysaccharide‑induced cardiac dysfunction in rats.

ALDH2 deficiency augments atherosclerosis through the USP14-cGAS-dependent polarization of proinflammatory macrophages

Aldehyde dehydrogenase 2 deficiency promotes atherosclerotic plaque instability through accelerating mitochondrial ROS-mediated vascular smooth muscle cell senescence

Pharmacological Activation Of Aldehyde Dehydrogenase 2 Protects Against Heatstroke-Induced Acute Lung Injury by Modulating Oxidative Stress and Endothelial Dysfunction

Aldehyde Dehydrogenase 2 Activation Ameliorates Ccl4-Induced Chronic Liver Fibrosis In Mice By Up-Regulating Nrf2/Ho-1 Antioxidant Pathway

Dynamic determination of Ox-LDL-induced oxidative/nitrosative stress in single macrophage by using fluorescent probes.

Abstract 699: Mitochondrial Aldehyde Dehydrogenase (aldh-2) Protects Against Lipopolysaccharide-induced Myocardial Contractile Dysfunction by Suppression of ER Stress via Regulation of Autophagy

Induction of ROS/RNS Dynamics in the Macrophage by Ox-LDL

Aldehyde dehydrogenase 2 deficiency reinforces formaldehyde-potentiated pro-inflammatory responses and glycolysis in macrophages

Non-lethal sonodynamic therapy facilitates the M1-to-M2 transition in advanced atherosclerotic plaques via activating the ROS-AMPK-mTORC1-autophagy pathway

Aldehyde dehydrogenase 2 protects cardiomyocytes against lipotoxicity via the AKT/glycogen synthase kinase 3 beta pathways

Allicin alleviated acrylamide-induced NLRP3 inflammasome activation via oxidative stress and endoplasmic reticulum stress in Kupffer cells and SD rats liver

Mitochondrial aldehyde dehydrogenase (ALDH2) rescues cardiac contractile dysfunction in an APP/PS1 murine model of Alzheimer’s disease via inhibition of ACSL4-dependent ferroptosis

Mitochondrial Aldehyde Dehydrogenase (ALDH2) Rescues Cardiac Contractile Dysfunction in an APP/PS1 Murine Model of Alzheimer's Disease Via Inhibition of ACSL4-dependent Ferroptosis.

ALDH2 attenuates myocardial pyroptosis through breaking down Mitochondrion-NLRP3 inflammasome pathway in septic shock

Aldehyde dehydrogenase 2 ameliorates doxorubicin-induced myocardial dysfunction through detoxification of 4-HNE and suppression of autophagy

Aldehyde Dehydrogenase 2 Preserves Mitochondrial Function in the Ischemic Heart: A Redox-dependent Mechanism for AMPK Activation by Thioredoxin-1